Sharps Technology (STSS) FCF Margin (2025)
Sharps Technology recorded quarterly FCF Margin of 693.92% in Q4 2025, up 93.4% quarter-over-quarter from 10506.95% in Q3 2025.
Sharps Technology's FCF Margin history runs 1 years deep, the most recent figure standing at 693.92% for Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn | 29.18% |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn | 11.58% |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn | 36.36% |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn | 7.55% |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn | -13.60% |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn | 15.50% |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn | 11.56% |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn | 2.81% |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn | 5.42% |
| 10 | Sharps Technology | 203.95 Mn | -56.54 Mn | 1.79 Mn | -693.92% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -693.92% |
| Sep 30, 2025 | -10,506.95% |